Study of FX006 in Patients With Osteoarthritis of the Knee

NCT01487161 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

229

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis of the Knee

Interventions

DRUG: FX006
DRUG: TCA IR

Sponsor

Pacira Pharmaceuticals, Inc